Growth Metrics

Nu-Med Plus (NUMD) Accumulated Expenses (2012 - 2025)

Nu-Med Plus recorded quarterly Accumulated Expenses of $18009.0 in Q4 2025, up 17.06% quarter-over-quarter from $15384.0 in Q3 2025, and up 22.35% year-over-year from $14719.0 in Q4 2024.

Nu-Med Plus' Accumulated Expenses history runs 14 years deep, the most recent figure standing at $18009.0 for Q4 2025.

  • In Q4 2025, Accumulated Expenses rose 22.35% year-over-year to $18009.0; the TTM figure through Dec 2025 stood at $18009.0 (up 22.35% YoY), while the FY2025 annual figure was $18009.0, up 22.35% from the prior year.
  • Accumulated Expenses came in at $18009.0 for Q4 2025 at Nu-Med Plus, up from $15384.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $144555.0 in Q3 2022 to a low of $1000.0 in Q4 2022.
  • A 5-year average of $40143.2 and a median of $17531.0 in 2024 frame the typical range for Accumulated Expenses.
  • Across the five-year window, Accumulated Expenses soared 750.93% in 2021 and tumbled 98.92% in 2022, its largest moves.
  • Nu-Med Plus' Accumulated Expenses stood at $92555.0 in 2021, then sank by 98.92% to $1000.0 in 2022, then surged by 500.0% to $6000.0 in 2023, then soared by 145.32% to $14719.0 in 2024, then climbed by 22.35% to $18009.0 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $18009.0, $15384.0, and $13493.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nu-Med Plus - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 18,009.00
Sep 30, 2025 15,384.00
Jun 30, 2025 13,493.00
Mar 31, 2025 19,747.00
Dec 31, 2024 14,719.00
Sep 30, 2024 17,053.00
Jun 30, 2024 19,094.00
Mar 31, 2024 14,547.00
Dec 31, 2023 6,000.00
Sep 30, 2023 4,740.00
Jun 30, 2023 3,479.00
Mar 31, 2023 2,233.00
Dec 31, 2022 1,000.00
Sep 30, 2022 144,555.00
Jun 30, 2022 134,555.00
Mar 31, 2022 113,555.00
Dec 31, 2021 92,555.00
Sep 30, 2021 71,062.00
Jun 30, 2021 56,042.00
Mar 31, 2021 41,041.00
Dec 31, 2020 26,019.00
Sep 30, 2020 10,975.00
Jun 30, 2020 6,586.00
Mar 31, 2020 11,229.00
Dec 31, 2019 9,579.00
Sep 30, 2019 112,651.00
Jun 30, 2019 108,597.00
Mar 31, 2019 104,565.00
Dec 31, 2018 19,546.00
Sep 30, 2018 96,511.00
Jun 30, 2018 94,922.00
Mar 31, 2018 88,425.00
Dec 31, 2017 84,411.00
Sep 30, 2017 80,566.00
Jun 30, 2017 76,454.00
Mar 31, 2017 72,488.00
Dec 31, 2016 66,079.00
Sep 30, 2016 62,081.00
Jun 30, 2016 58,083.00
Mar 31, 2016 56,570.00
Dec 31, 2015 52,637.00
Sep 30, 2015 48,626.00
Jun 30, 2015 44,649.00
Mar 31, 2015 40,683.00
Dec 31, 2014 36,728.00
Sep 30, 2014 36,728.00
Jun 30, 2014 28,752.00
Mar 31, 2014 24,785.00
Dec 31, 2013 20,862.00
Sep 30, 2013 15,317.00
Jun 30, 2013 12,080.00
Mar 31, 2013 9,312.00
Dec 31, 2012 7,400.00